Uscom Limited · ASX:UCM

Uscom — Investor Presentation (November 2004)

22 slides from Uscom's investor presentation, Nov 30, 2004

  1. Slide 1: USCOM Ultrasonic Cardiac Output Measurement

    USCOM Ultrasonic Cardiac Output Measurement

  2. Slide 2: Why are we here?

    ~ Why are we here? * Awareness ¢ Broaden share register: European Institutions * Explore options for future growth

  3. Slide 3: Australian medical devices company

    * Australian medical devices company * Founded 1999 ¢ Headquartered in Sydney * Experienced management in Business, Science & Operations Ro HDS (Chairman

  4. Slide 4: About USCOM

    ‘About USCOM ¢ ASX Listed December ‘03 ¢ Market cap: A$120 million ¢ Cash resources: A$12 million ¢ 16 full-time staff

  5. Slide 5: The USCOM Core proposition

    Gece The USCOM Core proposition e Cardiac output is the single most important measure of human health. e Current methods of cardiac monitoring are expensive, invasive, technically difficult or with variable accuracy. e Huge demand for a safe, more accurate and efficient solution.

  6. Slide 6: The USCOM Core proposition

    e049 0 . : The USCOM Core proposition “Non-invasive hemodynamic monitoring number one unmet need.” Survey of 700 physicians & nurses worldwide, conducted by General Electric Medical Systems. GE Medical Systems ae

  7. Slide 7: USCOM

    - USCOM atheter

  8. Slide 8: The current gold standard

    The current gold standard, Alternative methods in an era of Evide c e- -in practice ~ and in funding With a focus on Goal Dire s dangerous & expensive ceurat and/or invasive icine erapy proportions

  9. Slide 9: Slide 9

  10. Slide 10: Progress To Date

    Progress To Date ¢ Core patents since May, 2003 ¢ IP portfolio: 16 applications ¢ Marketing launch: Europe & Asia Reg. approvals: China, Europe & Japan US launch planned for 2005

  11. Slide 11: Progress To Date

    Progress To Date ¢ A$12 million cash in hand * Cash spend rate: A$700,000 per Q * Technology proven Demand & Revenue proven ‘Science proven: 15 studies presented

  12. Slide 12: Sales & Distribution

    ~ Sales & Distribution <n Beaver eee ginal ~~ Oe LEAD Medical * Medizintechnik Novadiem Pacis TEMA... Pacific Medical ” Systems “GLOBAL DISTRIBUTION. «© y & MARKETING:-NETWORK ~~ ficient: (EXCLUDING USA) ~. Systems

  13. Slide 13: Sales & Distribution Strategy

    ~ Sales & Distribution Strategy China Japan South Asia S.E. Asia Australia UK Taiwan Korea Middle East TOTAL TO DATE:

  14. Slide 14: Great Ormond Street Hospital, London

    vines Great Ormond Street Hospital, London An USCOM customer and important paediatrics research site

  15. Slide 15: Dr Karsten Knobloch

    Dr Karsten Knobloch Hannover, Germany with USCOM in ER and retrieval helicopter

  16. Slide 16: Dr Karsten Knobloch

    ee ie a Dr Karsten Knobloch Hannover, Germany with USCOM in ER and retrieval helicopter

  17. Slide 17: Dr Karsten Knobloch

    Dr Karsten Knobloch Hannover, Germany with USCOM in ER and retrieval helicopter . es

  18. Slide 18: Dr Peter Lichtenthal testimonial

    sis “USCOM has the potential to be a very important monitoring device. We are looking forward to its US launch.” Dr Peter Lichtenthal, Associate Professor Cardiathoracic Anaesthesia University of Arizona Health Sciences Centre

  19. Slide 19: The case for USCOM

  20. Slide 20: Product Evolution

  21. Slide 21: Product Evolution

    Product Evolution

  22. Slide 22: USCOM Ultrasonic Cardiac Output Measurement

    USCOM Ultrasonic Cardiac Output Measurement

Uscom — Investor Presentation (November 2004) on 6ix